Related Experiment Video
Updated: Sep 3, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Nearly All Cancer Survivors Return to Primary Care
Laura C Pinheiro1, Mangala Rajan2, Monika M Safford2
1From Department of Medicine, Division of General Internal Medicine, Weill Cornell Medicine, New York, NY (LCP, MR, MMS, LMK); Department of Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY (DMN). lcp2003@med.cornell.edu).
Background:
During cancer treatments, patients often defer primary care and comorbidity management, which may not be optimal for overall health when patients transition into survivorship. We sought to quantify primary care utilization among cancer survivors who are ≥2 years post cancer treatments.
Methods:
951 cancer survivors were included in this national, prospective cohort study using the Regional Geographic and Racial Differences in Stroke (REGARDS) data.
Results:
Nearly all (91.6%) cancer survivors had at least 1 annual PCP visit and most (54.6%) had a PCP as their dominant provider.
Conclusion:
These findings underscore the urgent need for smooth handoffs from oncology back to primary care.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Patient-centered Care
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Traditional Level Of Health Care System
The preventive healthcare service includes tests for screening. Preventive health care services include identifying and reducing disease risk...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...